Variant report

Variant	esv34939
Chromosome Location	chr12:371786-433151
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:362)
CpG islands
(count:611)
Chromatin interactive
region (count:22)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:362 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr12:373538-373815	K562	blood:	n/a	n/a
2	BATF	chr12:382502-382775	GM12878	blood:	n/a	n/a
3	BCL3	chr12:377133-378098	A549	lung:	n/a	n/a
4	BRCA1	chr12:388853-388959	Hela-S3	cervix:	n/a	n/a
5	CEBPB	chr12:402418-402703	A549	lung:	n/a	n/a
6	CEBPB	chr12:430918-431082	HepG2	liver:	n/a	chr12:430999-431010
7	CEBPB	chr12:400574-400774	K562	blood:	n/a	chr12:400672-400683
8	CEBPB	chr12:430700-431242	A549	lung:	n/a	chr12:430999-431010
9	CEBPB	chr12:430788-431260	ECC-1	luminal epithelium:	n/a	chr12:430999-431010
10	CEBPB	chr12:417783-417986	MCF-7	breast:	n/a	n/a
11	CEBPB	chr12:402382-402717	A549	lung:	n/a	n/a
12	CEBPB	chr12:430794-431143	A549	lung:	n/a	chr12:430999-431010
13	CEBPB	chr12:373496-373744	K562	blood:	n/a	n/a
14	CEBPB	chr12:400511-400815	IMR90	lung:	n/a	chr12:400672-400683
15	CEBPB	chr12:430821-431182	HepG2	liver:	n/a	chr12:430999-431010
16	CEBPB	chr12:402372-402734	IMR90	lung:	n/a	n/a
17	CEBPB	chr12:402424-402682	K562	blood:	n/a	n/a
18	CEBPB	chr12:430744-431232	ECC-1	luminal epithelium:	n/a	chr12:430999-431010
19	CEBPB	chr12:400603-400855	A549	lung:	n/a	chr12:400672-400683
20	CEBPB	chr12:402384-402731	K562	blood:	n/a	n/a
21	CEBPB	chr12:430827-431161	IMR90	lung:	n/a	chr12:430999-431010
22	CEBPB	chr12:430841-431131	H1-hESC	embryonic stem cell:	n/a	chr12:430999-431010
23	CEBPB	chr12:417631-418127	MCF-7	breast:	n/a	n/a
24	CEBPB	chr12:430816-431188	A549	lung:	n/a	chr12:430999-431010
25	CEBPB	chr12:430850-431088	HepG2	liver:	n/a	chr12:430999-431010
26	CEBPB	chr12:430799-431225	MCF-7	breast:	n/a	chr12:430999-431010
27	CEBPB	chr12:430807-431200	Hela-S3	cervix:	n/a	chr12:430999-431010
28	CEBPB	chr12:400521-400792	HepG2	liver:	n/a	chr12:400672-400683
29	CEBPB	chr12:430833-431166	K562	blood:	n/a	chr12:430999-431010
30	CEBPB	chr12:402393-402715	Hela-S3	cervix:	n/a	n/a
31	CEBPB	chr12:400492-400851	Hela-S3	cervix:	n/a	chr12:400672-400683
32	CEBPB	chr12:430737-431267	MCF-7	breast:	n/a	chr12:430999-431010
33	CEBPB	chr12:402430-402705	H1-hESC	embryonic stem cell:	n/a	n/a
34	CEBPB	chr12:402270-402740	A549	lung:	n/a	n/a
35	CEBPB	chr12:402387-402742	HepG2	liver:	n/a	n/a
36	CEBPD	chr12:430839-431061	HepG2	liver:	n/a	n/a
37	CTCF	chr12:430880-431030	AG04449	skin:	n/a	n/a
38	CTCF	chr12:430820-430970	AG04450	lung:	n/a	n/a
39	CTCF	chr12:430884-431051	MCF-7	breast:	n/a	n/a
40	CTCF	chr12:430861-431017	SK-N-SH_RA	brain:	n/a	n/a
41	CTCF	chr12:430880-431030	BJ	skin:	n/a	n/a
42	CTCF	chr12:430880-431030	HFF	foreskin:	n/a	n/a
43	CTCF	chr12:376720-376870	SAEC	small airway:	n/a	n/a
44	CTCF	chr12:430859-431073	Medullo	brain:	n/a	n/a
45	CTCF	chr12:430880-431030	HEEpiC	esophagus:	n/a	n/a
46	CTCF	chr12:430905-431030	HUVEC	blood vessel:	n/a	n/a
47	CTCF	chr12:430748-431179	MCF-7	breast:	n/a	n/a
48	CTCF	chr12:430840-430990	BJ	skin:	n/a	n/a
49	CTCF	chr12:430900-431050	HA-sp	spinal cord:	n/a	n/a
50	CTCF	chr12:430801-431087	GM12878	blood:	n/a	n/a

(count:611 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:372790-372840	HepG2	liver:	n/a
2	chr12:372790-372840	HepG2	liver:	n/a
3	chr12:372049-372099	CMK	blood:	n/a
4	chr12:371950-372000	MCF10A-Er-Src	breast:	n/a
5	chr12:371950-372000	HCF	heart:	n/a
6	chr12:371950-372000	NH-A	brain:	n/a
7	chr12:372139-372189	U87	brain:	n/a
8	chr12:372790-372840	Jurkat	blood:	n/a
9	chr12:392537-392587	HNPCEpiC	eye:	n/a
10	chr12:378771-378821	AG09319	gingival:	n/a
11	chr12:372790-372840	HEK293	kidney:	embryo
12	chr12:372790-372840	GM12878	blood:	n/a
13	chr12:371916-371966	AoSMC	blood vessel:	n/a
14	chr12:372246-372296	HL-60	blood:	n/a
15	chr12:372139-372189	LNCaP	prostate:	n/a
16	chr12:372246-372296	H1-hESC	embryonic stem cell:	embryo
17	chr12:372246-372296	BE2_C	brain:	n/a
18	chr12:371950-372000	HIPEpiC	eye:	n/a
19	chr12:372246-372296	T-47D	breast:	n/a
20	chr12:372139-372189	HPAEpiC	pulmonary alveolar:	n/a
21	chr12:372139-372189	MCF-7	breast:	n/a
22	chr12:378771-378821	H1-hESC	embryonic stem cell:	embryo
23	chr12:392537-392587	Hela-S3	cervix:	n/a
24	chr12:371916-371966	Hepatocyte	liver:	n/a
25	chr12:372246-372296	ECC-1	luminal epithelium:	n/a
26	chr12:392537-392587	BJ	skin:	n/a
27	chr12:372259-372309	H1-hESC	embryonic stem cell:	embryo
28	chr12:392537-392587	HEK293	kidney:	embryo
29	chr12:372049-372099	AG04449	skin:	fetal
30	chr12:372790-372840	IMR90	lung:	fetal
31	chr12:372139-372189	PrEC	prostate:	n/a
32	chr12:372139-372189	HEK293	kidney:	embryo
33	chr12:372259-372309	MCF10A-Er-Src	breast:	n/a
34	chr12:378771-378821	Jurkat	blood:	n/a
35	chr12:371916-371966	NT2-D1	testis:	n/a
36	chr12:372191-372241	Caco-2	colon:	n/a
37	chr12:371916-371966	U87	brain:	n/a
38	chr12:372049-372099	HRPEpiC	eye:	n/a
39	chr12:372259-372309	HCPEpiC	choroid plexus:	n/a
40	chr12:378771-378821	HUVEC	blood vessel:	n/a
41	chr12:372246-372296	SAEC	small airway:	n/a
42	chr12:371916-371966	LNCaP	prostate:	n/a
43	chr12:372191-372241	NB4	blood:	n/a
44	chr12:372139-372189	HIPEpiC	eye:	n/a
45	chr12:372246-372296	GM12892	blood:	n/a
46	chr12:378771-378821	HepG2	liver:	n/a
47	chr12:392537-392587	NB4	blood:	n/a
48	chr12:372139-372189	IMR90	lung:	fetal
49	chr12:371950-372000	HUVEC	blood vessel:	n/a
50	chr12:372191-372241	Hepatocyte	liver:	n/a

(count:22 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr12:391396..394249-chr12:395350..397810,2	K562	blood:
2	chr12:391396..393092-chr12:395064..396850,2	K562	blood:
3	chr12:399444..402323-chr12:403579..405598,2	K562	blood:
4	chr12:369816..372336-chr12:398324..400743,2	K562	blood:
5	chr12:381899..385111-chr12:386819..388918,3	K562	blood:
6	chr12:418157..420807-chr12:497062..498857,2	MCF-7	breast:
7	chr12:423846..425522-chr12:432470..434859,2	K562	blood:
8	chr12:424975..427047-chr12:431144..433406,2	MCF-7	breast:
9	chr12:303209..305233-chr12:388816..390804,2	K562	blood:
10	chr12:371815..374343-chr12:375834..377592,4	K562	blood:
11	chr12:378409..380462-chr12:383368..386178,2	MCF-7	breast:
12	chr12:391396..393092-chr12:395064..396850,2	K562	blood:
13	chr12:423846..425522-chr12:432470..434859,2	K562	blood:
14	chr12:371815..373339-chr12:375834..377443,2	K562	blood:
15	chr12:402335..404067-chr12:405685..407593,2	K562	blood:
16	chr12:381899..385111-chr12:386819..388918,3	K562	blood:
17	chr12:381899..384416-chr12:386819..388918,2	K562	blood:
18	chr12:391396..394249-chr12:395350..397810,2	K562	blood:
19	chr12:381899..384416-chr12:386819..388918,2	K562	blood:
20	chr12:378409..380462-chr12:383368..386178,2	MCF-7	breast:
21	chr12:371632..373367-chr12:383696..385601,2	MCF-7	breast:
22	chr12:402335..404067-chr12:405685..407593,2	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-KDM5A-1	chr12:383120-386289	ENSG00000261799.1

No data

Variant related genes	Relation type
KDM5A	TF binding region
SLC6A13	TF binding region
ENSG00000261799	TF binding region
KDM5A	CpG island
SLC6A13	CpG island
ENSG00000261799	CpG island
ENSG00000010379	chromatin interactions
ENSG00000073614	chromatin interactions
ENSG00000120647	chromatin interactions

Extended variants
information (count: 2483 )
Associated
traits (count: 84 )

Variant overlapped rSNPs/rCNVs (count:2483 , 50 per page) page: 1 2 3 4 5 6 7 ... 50

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs524468	chr12:371786-371787	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs563628461	chr12:371790-371791	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs529326143	chr12:371830-371831	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs550610245	chr12:371840-371841	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs368082174	chr12:371852-371853	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs533467329	chr12:371935-371936	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs552006160	chr12:372035-372036	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs566965623	chr12:372088-372089	Weak transcription Enhancers Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
9	rs534436193	chr12:372097-372098	Weak transcription Enhancers Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
10	rs555971755	chr12:372124-372125	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs567414137	chr12:372145-372146	Weak transcription Enhancers Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
12	rs537929364	chr12:372175-372176	Weak transcription Enhancers Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
13	rs556204538	chr12:372189-372190	Weak transcription Enhancers Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
14	rs541407624	chr12:372192-372193	Weak transcription Enhancers Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
15	rs533403394	chr12:372196-372197	Weak transcription Enhancers Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
16	rs577664333	chr12:372204-372205	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
17	rs548915874	chr12:372226-372227	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
18	rs73604849	chr12:372285-372286	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs572232255	chr12:372325-372326	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs542836189	chr12:372344-372345	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs528546257	chr12:372351-372352	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs560746793	chr12:372358-372359	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs183667999	chr12:372371-372372	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs1548904	chr12:372382-372383	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
25	rs151010095	chr12:372403-372404	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs183854313	chr12:372410-372411	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs140851785	chr12:372414-372415	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs797765	chr12:372438-372439	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
29	rs568493118	chr12:372495-372496	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs560867326	chr12:372526-372527	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs76907414	chr12:372616-372617	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs369996227	chr12:372655-372656	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs549637877	chr12:372703-372704	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs567819117	chr12:372757-372758	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs34328511	chr12:372770-372771	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs16928976	chr12:372773-372774	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs549873540	chr12:372820-372821	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats Flanking Active TSS	CpG island	1 gene(s)	Overlapped CNVs	n/a
38	rs35585051	chr12:372851-372852	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs538812740	chr12:372959-372960	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs10744561	chr12:372968-372969	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
41	rs145514791	chr12:372970-372971	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs553467540	chr12:373008-373009	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs572353471	chr12:373023-373024	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs551796119	chr12:373078-373079	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs74057651	chr12:373079-373080	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs575786758	chr12:373086-373087	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs579526	chr12:373120-373121	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
48	rs562674454	chr12:373121-373122	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs578016164	chr12:373160-373161	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs368268362	chr12:373164-373165	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:84)

Disease	PMID	Source
Cancer	20164920	CNVD
Myelofibrosis	22110671	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD
Glaucoma	21310917	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Malignant peripheral nerve sheath tumor	19844265	CNVD
Squamous cell cancer	19607727	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Mental retardation	17847001	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
abnormal development	18461090	CNVD
Ovarian cancer	20844748	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Medulloblastoma	16968546	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Breast cancer	22032731	CNVD
Cancer	21183584	CNVD
Myxofibrosarcoma	16751306	CNVD
Non-small cell lung cancer	21829676	CNVD
Ovarian neoplasms	16753589	CNVD
Prostate cancer	21965145	CNVD
Acute myeloid leukemia	16864856	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Disorders of sex development	21048976	CNVD
Glioblastoma multiforme	21080181	CNVD
Liposarcoma	21253554	CNVD
Prostate cancer	19156837	CNVD
Emphysema	19352772	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Malignant germ cell tumour	17285132	CNVD
Melanoma	18172304	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Wilms tumour	21544195	CNVD
Squamous cell cancer	21044232	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Breast cancer	21264507	CNVD
Cancer	16751803	CNVD
Testicular cancer	18059402	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Seminomas	18059402	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Testicular germ cell tumor	18059402	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
small cell lung cancer	20016488	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Breast cancer	21364760	CNVD
Developmental delay	21147756	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Acute myeloid leukemia	20729466	CNVD
Breast cancer	21858162	CNVD
Breast cancer	21509527	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21785460	CNVD
Autism	22495309	CNVD
Ovarian cancer	21720365	CNVD
Myelodysplastic syndrome	21251322	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Cancer	20164919	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Glioblastoma multiforme	22291905	CNVD

Chromatin state (count:1510 , 50 per page) page: 1 2 3 4 5 6 7 ... 31

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:371200-372000	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
2	chr12:371200-372000	Flanking Active TSS	Fetal Kidney	kidney
3	chr12:371200-372400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
4	chr12:371200-372400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
5	chr12:371200-372400	Enhancers	Fetal Muscle Leg	muscle
6	chr12:371200-372400	Enhancers	HepG2	liver
7	chr12:371200-373200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
8	chr12:371400-372200	Weak transcription	Thymus	Thymus
9	chr12:371400-372400	Bivalent Enhancer	Fetal Lung	lung
10	chr12:371400-373400	Enhancers	K562	blood
11	chr12:371600-372000	Enhancers	ES-I3 Cell Line	embryonic stem cell
12	chr12:371600-372000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
13	chr12:371600-372000	Enhancers	iPS-18 Cell Line	embryonic stem cell
14	chr12:371600-372000	Flanking Active TSS	HSMMtube	muscle
15	chr12:371600-372400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
16	chr12:371600-372600	Enhancers	Fetal Heart	heart
17	chr12:371600-373600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
18	chr12:371600-373600	Enhancers	HSMM	muscle
19	chr12:371800-372000	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
20	chr12:371800-372200	Enhancers	Breast Myoepithelial Primary Cells	Breast
21	chr12:371800-372400	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
22	chr12:371800-372600	Enhancers	Placenta	Placenta
23	chr12:371800-373000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
24	chr12:371800-373400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
25	chr12:371800-373400	Enhancers	NH-A	brain
26	chr12:371800-373600	Weak transcription	Primary T helper naive cells from peripheral blood	blood
27	chr12:371800-376800	Weak transcription	Brain Anterior Caudate	brain
28	chr12:372000-372200	Enhancers	Fetal Kidney	kidney
29	chr12:372000-372400	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
30	chr12:372000-372400	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
31	chr12:372000-372800	Enhancers	HSMMtube	muscle
32	chr12:372000-373400	Weak transcription	iPS-18 Cell Line	embryonic stem cell
33	chr12:372000-376200	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
34	chr12:372000-376400	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
35	chr12:372000-379200	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
36	chr12:372200-372400	Enhancers	HUES6 Cell Line	embryonic stem cell
37	chr12:372200-372400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
38	chr12:372200-372400	Flanking Active TSS	Fetal Kidney	kidney
39	chr12:372200-372400	Bivalent Enhancer	Fetal Stomach	stomach
40	chr12:372200-372400	Enhancers	Lung	lung
41	chr12:372200-372400	Enhancers	Thymus	Thymus
42	chr12:372200-372400	Bivalent Enhancer	NHEK	skin
43	chr12:372200-373000	Enhancers	Osteobl	bone
44	chr12:372200-373200	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
45	chr12:372200-373200	Enhancers	Muscle Satellite Cultured Cells	--
46	chr12:372400-372600	Enhancers	Fetal Kidney	kidney
47	chr12:372400-372800	Weak transcription	Lung	lung
48	chr12:372400-373000	Weak transcription	Thymus	Thymus
49	chr12:372400-377000	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
50	chr12:372400-377200	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links